NDATOPICALCREAMPriority Review
Approved
Aug 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 6h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALOTEX (haloprogin) is a topical antifungal cream approved in 1971 for fungal skin infections. The specific mechanism of action and treatment indications are not fully documented in available data. It represents a legacy dermatology product from Bristol Myers Squibb's portfolio.
LOE Approaching
With LOE approaching and minimal current commercial visibility, brand team size is likely limited and focused on transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HALOTEX offers minimal career growth opportunity given zero linked job openings and approaching loss of exclusivity. This assignment is best suited for transition management, cost optimization, or maintenance-phase commercial roles rather than career advancement.
Brand ManagerField Sales Representative
Worked on HALOTEX at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.